> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Stryker Nerve Ablator Cleared for Back Pain
- URL: https://www.fdaweb.com/stryker-nerve-ablator-cleared-for-back-pain/
- Published: 2025-05-19T12:00:00.000Z
- Updated: 2026-09-14T15:12:08.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5159206

FDA has cleared a Stryker 510(k) for its OptaBlate basivertebral nerve ablation (BVNA) system and its use for procedures providing vertebrogenic pain relief. BVNA is described by the company as a minimally invasive and innovative procedure that targets a key source of this pain, particularly in patients with specific MRI findings.

The procedure offers a significant improvement for patients, the company says, potentially avoiding more invasive treatments like surgery. The device’s key features include the ability to create a 1 cm lesion in seven minutes, a steerable curved introducer for precise targeting, and microinfusion technology that maintains hydration to reduce impedance errors and prevent tissue charring, it says.